Keyphrases
Insomnia
100%
Insomnia Treatment
35%
Chronic Insomnia
34%
Sleep Disturbance
31%
Psychiatric Disorders
30%
Sleep Disorders
28%
Sleep Problems
22%
Excessive Daytime Sleepiness
17%
Psychiatric Illness
17%
Benzodiazepine Receptor Agonists
17%
Indiplon
16%
Pharmacological Therapy
16%
Objective Sleep
15%
Subjective Sleep
15%
Mood Disorders
15%
Sleep Characteristics
15%
Anxiety Disorders
15%
Daytime Sleepiness
15%
Sleep-disordered Breathing
15%
Mental Disorders
15%
End User Searching
15%
Pharmacodynamics
13%
Cognitive Behavioral Therapy
13%
Non-benzodiazepine
13%
Narcolepsy
12%
Sleep Onset
12%
Ramelteon
11%
Healthcare Professionals
11%
United States
11%
Insomnia Disorder
10%
Sleep Medicine
10%
Insomnia Medications
10%
Daytime Sleep
10%
Polysomnography
10%
Suvorexant
9%
Modified Release
9%
Apnea-hypopnea Index
9%
Orexin Receptors
8%
Evidence-based
8%
American Academy of Sleep Medicine
7%
Marijuana
7%
Snoring
7%
Chronic Insomnia Disorder
7%
Cognitive Impairment
7%
Pharmacologic
7%
Pharmacotherapeutic Approaches
7%
Caffeine
7%
Optimal Treatment
7%
Rapid Eye Movement Sleep
7%
Survival Analysis
7%
Neuroscience
Sleep Disorder
91%
Receptor Agonists
30%
Agonist
25%
Pharmacokinetics
23%
Circadian Rhythm
23%
Eszopiclone
23%
Zolpidem
23%
Hypnotic
23%
Benzodiazepine Receptor
19%
Sleep Time
19%
Cognitive Behavioral Therapy
15%
Obstructive Sleep Apnea
15%
Zaleplon
15%
Cannabis
15%
Ramelteon
15%
Behavior (Neuroscience)
15%
Benzodiazepine
15%
Melatonin Receptor Agonist
13%
Daytime Somnolence
12%
Mental Disorder
11%
Gamma-Aminobutyric Acid
11%
Orexin
8%
Receptor Antagonist
8%
Primary Insomnia
8%
Tasimelteon
8%
Rapid Eye Movement Sleep
8%
Hypersomnia
7%
Opiate
7%
Melatonin
7%
Typical Antipsychotic
7%
Dietary Supplement
7%
Stereotypic Movement Disorder
7%
Nonbenzodiazepine
7%
Almorexant
7%
Suvorexant
7%
Dual Orexin Receptor Antagonist
7%
Antidepressant
7%
Behavioral Therapy
7%
Anxiety Disorder
7%
Sleep
7%
Z-Drug
7%
Antihistamines
7%
Mood Disorder
7%
Decision-Making Process
7%
Antidepressant Therapy
7%
Doxepin
7%
Histamine Receptor
7%
Melatonin 1 Receptor
6%
Melatonin 2 Receptor
6%
Orexin Receptor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sleep Disorder
68%
Disease
44%
Benzodiazepine Receptor Stimulating Agent
39%
Pharmacokinetics
31%
Hypnotic
30%
Pharmacodynamics
29%
Zolpidem
29%
Melatonin Receptor Agonist
27%
Sleep Disordered Breathing
26%
Ramelteon
19%
Eszopiclone
17%
4 Aminobutyric Acid
15%
Indiplon
15%
Orexin
14%
Tablet
14%
Symptom
14%
Antihistaminic Agent
13%
Narcolepsy
12%
Typical Antipsychotic
12%
Melatonin
11%
Antidepressant
11%
Adverse Event
11%
Suvorexant
10%
Clinical Trial
10%
Zaleplon
10%
Benzodiazepine
9%
Orexin Receptor Antagonist
9%
Neurologic Disease
8%
Cataplexy
8%
Medical History
7%
Histamine Agonist
7%
Mood Disorder
7%
Nonbenzodiazepine
7%
Almorexant
7%
Zolpidem Tartrate
7%
Pharmacotherapy
7%
Combination Therapy
7%
Sodium Oxybate
7%
Daytime Somnolence
6%
Apnea
6%
Prevalence
5%